Analysts: Sarepta Therapeutics Inc (AB3A.F)

AB3A.F on Frankfurt Stock Exchange

15.16EUR
25 Jul 2014
Price Change (% chg)

€0.96 (+6.75%)
Prev Close
€14.20
Open
€15.16
Day's High
€15.16
Day's Low
€15.16
Volume
--
Avg. Vol
358
52-wk High
€40.75
52-wk Low
€9.35

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.78 December 28 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 4 5
(2) OUTPERFORM 4 4 5 4
(3) HOLD 6 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.43 2.38 2.27 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 12 4.62 7.00 3.00 9.57
Quarter Ending Dec-14 12 4.54 7.00 2.50 24.61
Year Ending Dec-14 12 19.49 27.10 12.00 41.36
Year Ending Dec-15 12 48.57 245.70 0.38 119.46
Earnings (per share)
Quarter Ending Sep-14 14 -0.78 -0.62 -0.89 -0.89
Quarter Ending Dec-14 14 -0.85 -0.64 -1.13 -0.29
Year Ending Dec-14 14 -3.08 -2.49 -3.52 -2.98
Year Ending Dec-15 13 -2.95 -0.89 -4.13 -1.79

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-14 3.54 6.09 2.55 72.09
Quarter Ending Dec-13 4.53 2.63 1.90 42.03
Quarter Ending Sep-13 4.57 4.17 0.41 8.88
Quarter Ending Jun-13 5.08 2.95 2.12 41.86
Quarter Ending Mar-13 5.85 4.47 1.37 23.51
Earnings (per share)
Quarter Ending Mar-14 -0.80 -0.75 0.05 -5.91
Quarter Ending Dec-13 -0.69 -0.23 0.46 -66.87
Quarter Ending Sep-13 -0.65 -1.24 0.59 -91.51
Quarter Ending Jun-13 -0.61 -0.60 0.01 -1.49
Quarter Ending Mar-13 -0.62 -1.32 0.70 -112.63

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 4.62 4.58 4.58 4.53 9.57
Quarter Ending Dec-14 4.54 4.50 4.50 4.25 24.61
Year Ending Dec-14 19.49 19.34 19.34 19.03 41.36
Year Ending Dec-15 48.57 51.07 51.07 47.86 119.46
Earnings (per share)
Quarter Ending Sep-14 -0.78 -0.77 -0.77 -0.80 -0.89
Quarter Ending Dec-14 -0.85 -0.83 -0.83 -0.87 -0.29
Year Ending Dec-14 -3.08 -3.07 -3.07 -3.14 -2.98
Year Ending Dec-15 -2.95 -2.85 -2.85 -2.95 -1.79

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 1 0 1 0
Year Ending Dec-15 0 0 1 0
Earnings
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks